System Transmission

Top Signal

100#1 JOB

Activity

2162Ripe

+919 today

System

Live1m

Terminal Asset View

stockNASDAQ

ATNM

$1.11-1.77%

Actinium Pharmaceuticals Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

23Neutral

Live Analysis Active

Company Mission

Actinium Pharmaceuticals creates cancer treatments that use radioactive particles to target and destroy cancer cells while sparing healthy tissue. Doctors and hospitals would use these treatments for patients with certain types of blood cancers. The company makes money through research funding and hopes to earn revenue from selling approved drugs to healthcare providers in the future.

ATN

Industry Context

This company operates in the biotechnology sector, which focuses on developing new medical treatments. Biotech companies often have volatile stock prices because their value depends heavily on research results and regulatory approvals for their experimental drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

67Matrix

Market Momentum

42.7— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.3x— Normal Volume

Today's Change

-1.77%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ATNM across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:07 PM UTC

As-of 03-14-2026 21:52 UTC

Develops cancer treatments using radioactive drugs and makes money by selling these therapies to hospitals and research centers.

Price below key moving averages, suggesting the stock is in a downtrend that needs to reverse for momentum to shift showing consolidation pattern.

Technical squeeze pattern detected, indicating potential for a breakout move when price compresses between support and resistance levels, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...